Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV

BACKGROUND: Rosuvastatin is a lipid-lowering agent widely prescribed in people living with HIV, which is actively transported into the liver, making it a potential victim of drug–drug interactions with antiretroviral agents. OBJECTIVES: The aims of this study were to characterise the pharmacokinetic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Pharmacokinet
Main Authors: Courlet, Perrine, Guidi, Monia, Alves Saldanha, Susana, Stader, Felix, Traytel, Anna, Cavassini, Matthias, Stoeckle, Marcel, Buclin, Thierry, Marzolini, Catia, Decosterd, Laurent A., Csajka, Chantal
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2020
Teme:
Original Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7932937/
https://ncbi.nlm.nih.gov/pubmed/33124006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-020-00946-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki